ArticlePloS one2013

No evidence for selection of HIV-1 with enhanced gag-protease or Nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial.

Denis R Chopera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.